| Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′ s main protease M Mahdi, JA Mótyán, ZI Szojka, M Golda, M Miczi, J Tőzsér Virology journal 17, 1-8, 2020 | 98 | 2020 |
| Potential resistance of SARS-CoV-2 main protease (Mpro) against protease inhibitors: lessons learned from HIV-1 protease JA Mótyán, M Mahdi, G Hoffka, J Tőzsér International journal of molecular sciences 23 (7), 3507, 2022 | 49 | 2022 |
| Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19 M Mahdi, L Hermán, JM Réthelyi, BL Bálint International Journal of Molecular Sciences 23 (7), 3812, 2022 | 22 | 2022 |
| Functional study of the retrotransposon-derived human PEG10 protease M Golda, JA Mótyán, M Mahdi, J Tőzsér International Journal of Molecular Sciences 21 (7), 2424, 2020 | 19 | 2020 |
| Inhibition profiling of retroviral protease inhibitors using an HIV-2 modular system M Mahdi, Z Szojka, JA Mótyán, J Tőzsér Viruses 7 (12), 6152-6162, 2015 | 19 | 2015 |
| Inhibitory effects of HIV-2 Vpx on replication of HIV-1 M Mahdi, Z Szojka, JA Mótyán, J Tőzsér Journal of Virology 92 (14), 10.1128/jvi. 00554-18, 2018 | 13 | 2018 |
| Analysis of networks of host proteins in the early time points following HIV transduction É Csősz, F Tóth, M Mahdi, G Tsaprailis, M Emri, J Tőzsér BMC bioinformatics 20, 1-18, 2019 | 10 | 2019 |
| A modular system to evaluate the efficacy of protease inhibitors against HIV-2 M Mahdi, K Matúz, F Tóth, J Tőzsér PLoS One 9 (11), e113221, 2014 | 9 | 2014 |
| Monocytes in neonatal immunity M Mahdi, L Maródi NeoReviews 11 (10), e558-e565, 2010 | 6 | 2010 |
| Fabry-betegség–terápiás útmutató T Constantin, A Székely, A Ponyi, V Gulácsy, C Ambrus, K Kádár, ... | 6 | 2010 |
| Cellular proteo-transcriptomic changes in the immediate early-phase of lentiviral transduction TR Linkner, V Ambrus, B Kunkli, ZI Szojka, G Kalló, É Csősz, A Kumar, ... Microorganisms 9 (11), 2207, 2021 | 4 | 2021 |
| Nijmegen Breakage syndrome M Erdős, B Tóth, P Juhász, M Mahdi, L Maródi Orvosi Hetilap 151 (16), 665-673, 2010 | 4 | 2010 |
| Management of Fabry disease T Constantin, A Székely, A Ponyi, V Gulácsy, C Ambrus, K Kádár, ... Orvosi Hetilap 151 (31), 1243-1251, 2010 | 3 | 2010 |
| Identification of SARS-CoV-2 Main protease (Mpro) cleavage sites using two-dimensional electrophoresis and in silico cleavage site prediction N Miltner, G Kalló, É Csősz, M Miczi, T Nagy, M Mahdi, JA Mótyán, ... International Journal of Molecular Sciences 24 (4), 3236, 2023 | 2 | 2023 |
| Aspects of the endothelin system in colorectal cancer MR Mahdi, RF Bedeer, HM Eltahry, MR Berger Biomedical Reviews 25, 1-13, 2014 | 2 | 2014 |
| Fabry disease diagnostic guideline T Constantin, É Rákóczi, A Ponyi, C Ambrus, K Kádár, I Vastagh, ... Orvosi Hetilap 151 (7), 243-249, 2010 | 2 | 2010 |
| Clinical spectrum and CSF findings in patients with West-Nile virus infection, a retrospective cohort review I Bakos, M Mahdi, L Kardos, A Nagy, I Várkonyi Diagnostics 12 (4), 805, 2022 | 1 | 2022 |
| Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients E Tóth, M Fagyas, B Nagy Jr, IM Siket, B Szőke, L Mártha, M Mahdi, ... GeroScience 46 (2), 1561-1574, 2024 | | 2024 |
| Transcriptomic analysis reveals key pathways influenced by HIV-2 Vpx ZI Szojka, B Kunkli, IW Kiarie, TR Linkner, AS Al-Muffti, H Ahmad, S Benkő, ... | | 2024 |
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection TR Linkner, V Ambrus, B Kunkli, ZI Szojka, G Kalló, É Csősz, A Kumar, ... International Journal of Molecular Sciences 25 (1), 380, 2023 | | 2023 |
